Concepedia

Bo Yang

BY

9

Publications

167

Citations

9

H-Index

1999

Active since

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Wuhan University

Vanderbilt University

University of Toronto

International University of Health and Welfare

Bo Yang is an author at Vertex Pharmaceuticals (United States) specializing in statistics, medicine, and bayesian statistics.

ORCID

Top concepts

Publications per year

1999–2022

9

Publications

9

Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma

Bo Yang, Zhihang Zhou, Li Chen et al. · Cancer Medicine · 2018 · 35 citations · Full text

Distinct Features of Probands With Early Repolarization and Brugada Syndromes Carrying SCN5A Pathogenic Variants

Zhonghe Zhang, Héctor Barajas-Martínez, Hao Xia et al. · Journal of the American College of Cardiology · 2021 · 33 citations · Full text

, , +8

Use of 5‐HT <sub>3</sub> receptor antagonists to prevent nausea and emesis caused by chemotherapy for patients with breast carcinoma in community practice settings

Jane T. Hickok, Joseph A. Roscoe, Gary R. Morrow et al. · Cancer · 1999 · 20 citations

Expression and mechanism of action of miR-196a in epithelial ovarian cancer

Bo Yang, Shengze Li, Ling Ma et al. · Asian Pacific Journal of Tropical Medicine · 2016 · 16 citations · Full text

Bayesian Optimal Phase II Design for Randomized Clinical Trials

Yujie Zhao, Bo Yang, J. Jack Lee et al. · Statistics in Biopharmaceutical Research · 2022 · 16 citations

, , +14

Rows per page

1–5 of 9